WINDTREE THERAPEUTICS INC /DE/ Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $24.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2025-04-15
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $24.00K, a 94.83% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $464.00K.
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2021 was -$186.00K, a 196.37% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 24 month |
|---|---|---|---|
| 2024-12-31 | $24.00K 10-K · filed 2025-04-15 | ||
| 2023-12-31 | $464.00K 10-K · filed 2025-04-15 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | $467.00K 10-K · filed 2023-03-31 | |
| 2021-12-31 | -$186.00K 10-K · filed 2023-03-31 | ||
| 2020-12-31 | $193.00K 10-K · filed 2022-03-31 | ||
| 2019-12-31 | $1.98M 10-K · filed 2021-03-29 | ||
| 2018-12-31 | $2.88M 10-K · filed 2020-04-03 | ||
| 2017-12-31 | $953.00K 10-K/A · filed 2019-04-23 | $1.22M 10-K · filed 2018-04-17 | |
| 2016-12-31 | -$1.22K 10-K · filed 2017-03-31 | ||
| 2015-12-31 | -$340.00 10-K · filed 2017-03-31 | $340.00K 10-K · filed 2016-03-29 | |
| 2014-12-31 | $2.13M 10-K · filed 2016-03-29 | ||
| 2013-12-31 | $766.00K 10-K · filed 2015-03-16 | ||
| 2012-12-31 | $988.00K 10-K · filed 2015-03-16 | ||
| 2011-12-31 | $1.76M 10-K · filed 2014-03-17 | ||
| 2010-12-31 | $4.75M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |